The long range goals of the Program Project are to elucidate and characterize basic mechanisms and pathways of growth related genes as they are normally expressed or inappropriately regulated in neoplastic transformation. Cancer is characterized by unregulated growth of cells which phenotypically fail to recapitulate normal differentiation and development. This project plans to analyze the abnormal regulation of the cancer cell through analyses of different but highly related pathways, beginning with growth factor genes through genes of receptors, extending to growth related genes activating transcription and developmentally regulated genes. Sequences mediating tissue and developmental stage specificity will be identified and used to modify lineage and temporal specific expression of oncogenes and other growth related genes through introduction into cells and transgenic mice. Ultimately, it is hoped to test the hypothesis that understanding of these normal and abnormal regulatory mechanisms will lead to logical approaches for treating neoplastic disease in man. Our shorter term research goals will focus on a growth factor (PDGF A-chain) gene overexpressed in several neoplastic cell lines; on the Bcl-2 gene, the putative oncogene of the t (14:18) human lymphoma: on the nerve growth factor (NGF) receptor gene in developmentally blocked, primary human neuroblastomas; on the NGF induced transcriptional regulatory genes NGFI-A, NGFI-B, and c-fos; and on the cathepsin G gene, a developmental marker of myelomonocytic cells. The work will involve molecular biology, cell biology, biochemistry, and immunology. cDNA and genomic cloning, DNA sequencing and identification of cis-acting gene flanking elements, identification and purification of trans-acting transcriptional proteins, in situ hybridization and immunoperoxidase analyses of tissue mRNA and protein expression respectively transcriptional analyses, and reconstitution experiments in transfected cells and in transgenic mice will be used. Common themes of research interest, research technologies, and reagents exist among these highly interactive investigators. Core Programs are planned in essential expertise and technologies coupled with an interactive program of weekly meetings devoted to discussions of ongoing laboratory progress, generation of new ideas, and journal review. These plus outside speakers, regular investigator programmatic reviews, and external and internal review groups will advance the research goals well beyond those achievable without the context of a program project.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA049712-02
Application #
3094378
Study Section
Special Emphasis Panel (SRC (Y1))
Project Start
1989-05-17
Project End
1994-04-30
Budget Start
1990-05-01
Budget End
1991-04-30
Support Year
2
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Barnes-Jewish Hospital
Department
Type
DUNS #
City
Saint Louis
State
MO
Country
United States
Zip Code
63110
Song, Sheng-Kwei; Qu, Zhican; Garabedian, Emily M et al. (2002) Improved magnetic resonance imaging detection of prostate cancer in a transgenic mouse model. Cancer Res 62:1555-8
Abdulkadir, S A; Carbone, J M; Naughton, C K et al. (2001) Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma. Hum Pathol 32:935-9
Abdulkadir, S A; Qu, Z; Garabedian, E et al. (2001) Impaired prostate tumorigenesis in Egr1-deficient mice. Nat Med 7:101-7
Nagarajan, R; Svaren, J; Le, N et al. (2001) EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron 30:355-68
Knudson, C M; Johnson, G M; Lin, Y et al. (2001) Bax accelerates tumorigenesis in p53-deficient mice. Cancer Res 61:659-65
Magee, J A; Araki, T; Patil, S et al. (2001) Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res 61:5692-6
Tourtellotte, W G; Keller-Peck, C; Milbrandt, J et al. (2001) The transcription factor Egr3 modulates sensory axon-myotube interactions during muscle spindle morphogenesis. Dev Biol 232:388-99
Sevetson, B R; Svaren, J; Milbrandt, J (2000) A novel activation function for NAB proteins in EGR-dependent transcription of the luteinizing hormone beta gene. J Biol Chem 275:9749-57
Abdulkadir, S A; Carvalhal, G F; Kaleem, Z et al. (2000) Tissue factor expression and angiogenesis in human prostate carcinoma. Hum Pathol 31:443-7
Rinkenberger, J L; Horning, S; Klocke, B et al. (2000) Mcl-1 deficiency results in peri-implantation embryonic lethality. Genes Dev 14:23-7

Showing the most recent 10 out of 144 publications